ZNF423在全基因组范围干扰急性淋巴细胞白血病的B系转录回路
该研究通过对1354例急性白血病样本的表达数据分析,发现ZNF423在多种B-ALL亚型中广泛表达,且在ETV6-RUNX1、B-other和TCF3-PBX1中平均表达最高。在KMT2A-AFF1 pro-B ALL模型中,CRISPR-Cas9敲除ZNF423降低细胞活力并显著延长异种移植小鼠生存。全基因组结合分析首次揭示ZNF423结合染色质与激活组蛋白标记缺失相关,干扰EBF1依赖的反式激活,并可通过竞争EBF1结合及与EBF1或SMADs互作抑制TGFB1启动子。
要点
- ZNF423在多种B-ALL亚型中广泛表达,以ETV6-RUNX1、B-other和TCF3-PBX1平均表达最高。
- 在KMT2A-AFF1 pro-B ALL模型中敲除ZNF423降低细胞活力并延长异种移植小鼠生存。
- ZNF423结合染色质与激活组蛋白标记缺失相关,并干扰EBF1依赖的转录激活。
核心结论
- ZNF423广泛存在于多种B-ALL亚型,其活性干扰B细胞淋巴生成并促进白血病发生。
研究设计与样本
- 对1354例急性白血病样本的多个表达数据集进行生物信息学分析。
- 在KMT2A-AFF1 pro-B ALL模型中进行CRISPR-Cas9介导的ZNF423基因敲除及异种移植实验。
- 全基因组结合模式、染色质景观和差异基因活性分析。
主要发现
- ZNF423平均表达在ETV6-RUNX1、B-other和TCF3-PBX1 ALL中最高,其次为BCR-ABL、超二倍体ALL和KMT2A重排ALL。
- KMT2A-AFF1 pro-B ALL模型中ZNF423敲除降低细胞活力并显著延长异种移植小鼠生存。
- 染色质结合的ZNF423与激活组蛋白标记缺失相关。
- ZNF423破坏EBF1依赖的反式激活,但不明显阻碍EBF1的抑制和先驱活性。
- ZNF423在缺乏EBF1时也富集于经典EBF1结合位点,提示不依赖EBF1的内在活性。
临床怎么用
- ZNF423可作为B-ALL尤其是特定亚型中潜在的治疗靶点,其敲除可降低细胞活力并延长生存。
- ZNF423通过干扰EBF1和SMAD相关转录回路发挥致白血病作用,需进一步转化验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Aberrant expression of the transcriptional modulator and early B-cell factor 1 (EBF1) antagonist ZNF423 has been implicated in B-cell leukemogenesis, but its impact on transcriptional circuitries in lymphopoiesis has not been elucidated in a comprehensive manner. Herein, in silico analyses of multiple expression data sets on 1354 acute leukemia samples revealed a widespread presence of ZNF423 in various subtypes of acute lymphoblastic leukemia (ALL). Average expression of ZNF423 was highest in ETV6-RUNX1, B-other, and TCF3-PBX1 ALL followed by BCR-ABL, hyperdiploid ALL, and KMT2A-rearranged ALL. In a KMT2A-AFF1 pro-B ALL model, a CRISPR-Cas9-mediated genetic ablation of ZNF423 decreased cell viability and significantly prolonged survival of mice upon xenotransplantation. For the first time, we characterized the genome-wide binding pattern of ZNF423, its impact on the chromatin landscape, and differential gene activities in a B-lineage context. In general, chromatin-bound ZNF423 was associated with a depletion of activating histone marks. At the transcriptional level, EBF1-dependent transactivation was disrupted by ZNF423, whereas repressive and pioneering activities of EBF1 were not discernibly impeded. Unexpectedly, we identified an enrichment of ZNF423 at canonical EBF1-binding sites also in the absence of EBF1, which was indicative of intrinsic EBF1-independent ZNF423 activities. A genome-wide motif search at EBF1 target gene loci revealed that EBF1 and ZNF423 co-regulated genes often contain SMAD1/SMAD4-binding motifs as exemplified by the TGFB1 promoter, which was repressed by ZNF423 outcompeting EBF1 by depending on its ability to bind EBF1 consensus sites and to interact with EBF1 or SMADs. Overall, these findings underscore the wide scope of ZNF423 activities that interfere with B-cell lymphopoiesis and contribute to leukemogenesis.
引用
- Iglesias P, Puller AC, Seoane M, et al. Genome-wide interference of ZNF423 with B-lineage transcriptional circuitries in acute lymphoblastic leukemia. Blood Adv. 2021. PMID: 33646306. doi:10.1182/bloodadvances.2020001844
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。